Table 2.
Parameter | Controls (n = 14) | Patients without MHE (n = 24) P vs control | Patients with mHE (n = 16) P vs control | Patients with MHE Pvs without MHE | P values |
cGMP in plasma (pmol/mL) | 0.64 ± 0.1 | 6.1 ± 0.6 | 8.7 ± 1.1 | ||
P < 0.0001 | P < 0.0001 | < 0.05 | < 0.0001 | ||
Nitrates + Nitrites (μmol/L) | 18 ± 1 | 38 ± 4 | 44 ± 9 | ||
P = 0.004 | P = 0.004 | NS | 0.001 | ||
3-Nitro-tyrosine (nmol/L) | 3.5 ± 1.2 | 10 ± 1 | 43 ± 6 | < 0.0001 | < 0.0001 |
P < 0.0001 | |||||
IL-6 (pg/mL) | 0.7 ± 0.2 | 2.3 ± 0.3 | 4.4 ± 0.5 | 0.001 | < 0.0001 |
P < 0.05 | P < 0.0001 | ||||
IL-18 (pg/mL) | 103 ± 13 | < 0.05 | < 0.0001 | ||
268 ± 39 | 404 ± 44 | ||||
P = 0.02 | P < 0.0001 | ||||
Ammonia (μmol/L) | 39 ± 4 | 84 ± 14 | 103 ± 33 | NS | 0.005 |
P = 0.04 | P = 0.006 |
One-way analysis of variance (ANOVA) followed by post-hoc Bonferroni’s multiple comparisons test were performed. Adjusted P values are shown. NS: Not significant.